BACKGROUND: The timing of surgery in asymptomatic severe mitral regurgitation remains controversial. This observational study sought to compare long-term outcomes of early surgery with a conventional ...

Discover how quadricuspid aortic valve impacts heart failure risk and survival compared with bicuspid valve. Find out more.

Six patients have successfully undergone the procedure since it was introduced in November 2024. Read more at ...

The FTC asserts that Edwards acquisition of JenaValve, given it now owns rival TAVR-AR firm JC Medical, will eliminate competition in the US artificial heart valve market.